These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 34916356)

  • 41. Risk factors associated with the mucormycosis epidemic during the COVID-19 pandemic.
    Bhanuprasad K; Manesh A; Devasagayam E; Varghese L; Cherian LM; Kurien R; Karthik R; Deodhar D; Vanjare H; Peter J; Michael JS; Thomas M; Samuel P; Varghese GM
    Int J Infect Dis; 2021 Oct; 111():267-270. PubMed ID: 34450284
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Efficacy of Posaconazole against Rhizopus oryzae Infection in Silkworm.
    Kurakado S; Matsumoto Y; Sugita T
    Med Mycol J; 2021; 62(3):53-57. PubMed ID: 34471035
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Post coronavirus disease mucormycosis: a deadly addition to the pandemic spectrum.
    Sharma S; Grover M; Bhargava S; Samdani S; Kataria T
    J Laryngol Otol; 2021 May; 135(5):442-447. PubMed ID: 33827722
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Rampant Increase in Cases of Mucormycosis in India and Pakistan: A Serious Cause for Concern during the Ongoing COVID-19 Pandemic.
    Ghazi BK; Rackimuthu S; Wara UU; Mohan A; Khawaja UA; Ahmad S; Ahmad S; Hasan MM; Dos Santos Costa AC; Ahmad S; Essar MY
    Am J Trop Med Hyg; 2021 Aug; 105(5):1144-1147. PubMed ID: 34460426
    [TBL] [Abstract][Full Text] [Related]  

  • 45. A case report of rhino-facial mucormycosis in a non-diabetic patient with COVID-19: a systematic review of literature and current update.
    Mohammadi F; Badri M; Safari S; Hemmat N
    BMC Infect Dis; 2021 Sep; 21(1):906. PubMed ID: 34479495
    [TBL] [Abstract][Full Text] [Related]  

  • 46. A look into the relationship between outdated coronavirus disease 2019 (COVID-19) treatment protocols and the overwhelming rise of mucormycosis in COVID-19 patients in India.
    Jamal SA; Rayapati A
    Infect Control Hosp Epidemiol; 2022 Nov; 43(11):1733-1735. PubMed ID: 34446122
    [No Abstract]   [Full Text] [Related]  

  • 47. Mass urine sugar testing to tackle post-COVID mucormycosis epidemic in India-MUSTARD concept.
    Garg P; Mittal S
    Diabetes Metab Syndr; 2021; 15(4):102177. PubMed ID: 34198108
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Overdiagnosis and overtreatment during the covid-19 pandemic.
    Devnani M
    BMJ; 2021 Nov; 375():n2688. PubMed ID: 34759004
    [No Abstract]   [Full Text] [Related]  

  • 49. Mixed mold infection with
    Bellanger AP; Navellou JC; Lepiller Q; Brion A; Brunel AS; Millon L; Berceanu A
    Infect Dis Now; 2021 Oct; 51(7):633-635. PubMed ID: 33527098
    [No Abstract]   [Full Text] [Related]  

  • 50. Rhino-orbital-cerebral mucormycosis: fungal epidemic in a viral pandemic.
    Chouhan M; Solanki B; Shakrawal N
    J Laryngol Otol; 2021 Nov; 135(11):981-986. PubMed ID: 34470691
    [TBL] [Abstract][Full Text] [Related]  

  • 51. COVID Associated Mucormycosis: A Study on the Spectrum of Clinical, Biochemical and Radiological Findings in A Series of Ten Patients.
    Pal P; Chatterjee N; Ghosh S; Ray BK; Mukhopadhyay P; Bhunia K; Srivastava SR; Adhikari S; Barman D; Banerjee B; Mukhopadhyay M; Pal J
    J Assoc Physicians India; 2021 Oct; 69(10):11-12. PubMed ID: 34781648
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Exudative retinal detachment in COVID-19 - associated rhino-orbital mucormycosis - A rare clinical finding.
    Sarkar S; Gokhale T; Kaliaperumal S; Singh R; Begam RB; Deb AK
    Indian J Ophthalmol; 2021 Sep; 69(9):2535-2537. PubMed ID: 34427262
    [TBL] [Abstract][Full Text] [Related]  

  • 53. COVID-19-associated mucormycosis: an epidemic within a pandemic.
    Sarda R; Swain S; Ray A; Wig N
    QJM; 2021 Oct; 114(6):355-356. PubMed ID: 34109406
    [No Abstract]   [Full Text] [Related]  

  • 54. Spectrum of intracranial complications of rhino-orbito-cerebral mucormycosis - resurgence in the era of COVID-19 pandemic: a pictorial essay.
    Kaushik KS; Ananthasivan R; Acharya UV; Rawat S; Patil UD; Shankar B; Jose A
    Emerg Radiol; 2021 Dec; 28(6):1097-1106. PubMed ID: 34605991
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Dental surveillance for Post-COVID mucormycosis.
    Balaji SM
    Indian J Dent Res; 2021; 32(1):2. PubMed ID: 34269227
    [No Abstract]   [Full Text] [Related]  

  • 56. Fulminant mucormycosis complicating coronavirus disease 2019 (COVID-19).
    Karimi-Galougahi M; Arastou S; Haseli S
    Int Forum Allergy Rhinol; 2021 Jun; 11(6):1029-1030. PubMed ID: 33713565
    [No Abstract]   [Full Text] [Related]  

  • 57. Mucormycosis-A serious threat in the COVID-19 pandemic?
    Szarpak L; Chirico F; Pruc M; Szarpak L; Dzieciatkowski T; Rafique Z
    J Infect; 2021 Aug; 83(2):237-279. PubMed ID: 34029629
    [No Abstract]   [Full Text] [Related]  

  • 58. [Fungal infections in the COVID-19 pandemic, the case of mucormycosis].
    Fernández NB
    Rev Argent Microbiol; 2021; 53(3):181-182. PubMed ID: 34579807
    [No Abstract]   [Full Text] [Related]  

  • 59. A prospective multicenter study on mucormycosis in India: Epidemiology, diagnosis, and treatment.
    Prakash H; Ghosh AK; Rudramurthy SM; Singh P; Xess I; Savio J; Pamidimukkala U; Jillwin J; Varma S; Das A; Panda NK; Singh S; Bal A; Chakrabarti A
    Med Mycol; 2019 Jun; 57(4):395-402. PubMed ID: 30085158
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Post COVID-19 Mucormycosis in the Second Wave-Realities, Uncertainties and Myths.
    Soman R; Sunavala A
    J Assoc Physicians India; 2021 Jul; 69(7):11-12. PubMed ID: 34431262
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.